INTRODUCTION
Nepal borders with Uttar Pradesh and Bihar states of India along the tropical climatic zone that is afflicted by a wide variety of endemic tropical diseases such as Malaria, Kala-azar, and Encephalitis etc. The wet paddy fields, tropical forest, close settlements, free and unrestricted human movement across the bordercontributes to the incidence of these diseases. This paper focuses on the communicable disease Kala-azar (KA); Visceral Leishmaniasis) which threatens almost one quarter of 1 the country's population . 2, 3 In Nepal, VL is primarily a disease of the poorest of the poor These people usually live in the mud houses having cracked walls and damp floors, which constitute excellent condition for attraction and hiding of sand-fly. Moreover, majority of these people sleep outside of their houses during the summer, without bed nets, which is most favorable situation for the sand-fly to bite and transmit the infection. Although VL cases are still being reported at lower rate in Nepal since 1998 but this might have also been due to out-migration to the Middle-.
East counties for employment and carry back infection into 4, 5 Nepal .
In Nepal, VL primarily manifests as fever, anaemia, hepato and splenomegaly, resulting in death if it is untreated. The diagnosis of VL in Nepal is largely based on clinical signs and symptoms, 6 usually combined with positive formal-gel test At present, the most widely used immunological tests to detect VL in Nepal are the nitrocellulose dipstick test that detects antibody to the recombinant amastigote antigen K39 (rK39), direct 7 agglutination test, and latex agglutination test .
. . His Majesty's Government of Nepal (HMG/N) has acknowledged the necessity of maintaining a healthy population as a means of poverty alleviation and in this regard, it has initiated measures for the control of KA and abatement of its disastrous effects on the households since the first KA case 8 was identified in the country in 1980 . Furthermore, it has been felt that simply addressing the disease from and epidemiological level has been insufficient, and that effective programs should take into account both the socio-economic 9 and behavioral factors of the KA susceptible household VL cases may be underestimated in these regions. Treatment failure with pentavalent antimonial (sodium stibogluconate [SSG] ) has been reported in the recent years in Nepal and as a result, a single dose liposomal Amphotericin B is currently. recommended by National Program of Nepal for kala-azar treatment. Not only is the emergence and spread of drug resistance troubling, but VL cases have been recently reported from the regions that were previously considered to be nonendemic in Nepal. (97.0%) of the respondents were males in the current study majority (50.5%) of the respondents were female, however it is supported by the study conducted in South Gondar where 15 majority of the respondents were female 60.7% .
MATERIAL AND METHODS
In our study young peoples are commonly affected then elderly. Age group between 15-30 years (31.25%), 31-45 years (25%), 46-60 years (18.75%), 61-75 years (12.5%), 76-85 years (12.5%). Young people's age group 15-30 years are commonly infected.
In my study among suspected cases of 75, 59 are found negative and 16 cases found infected from Kala-azar (rk39 test positive). It accounts 12% of total cases.
Of the total eighteen suspected patients with Kala-azar were tested by aldehyde and bone-marrow methods. Among them, 33.33% (6/18) were positive for aldehyde test only and 83.3% (5/6) for bone-11 marrow in terai region of Nepal.
In my study among 16 cases male are 14 and 2 are females. 85.7% male and 12.3% female. Males are more affected than females. The CFR in male was 13% and 11% during 1996 and 12 1997 and in female it was 8% and 13% respectively . In the study, majority (35.2%) of the respondents were 21-30 years age, which is consistent with the findings of study of Bihar 16 where 26.7% were between 25-34 years . Similar to the work by Ranjan and others, those individuals 21 years and older accounted for the highest percentage of cases (42%), whereas the current study also had 40% of the total cases in children 17 ages 0-10 years .
CONCLUSION
Visceral leishmaniasis( Kala-azar) first appeared in the Eastern terai parts of Nepal during 1982. Due to proper vector control and effective treatment incidence of Kala-azar decreasing since last few years. But due to lack of easy drug availability cases of kala-azar can be seen in many parts of Nepal most commonly terai region of Nepal. Regular epidemiological surveillance in all terai districts is warranted in view of migration of Kala-azar cases from endemic districts coupled with the presence of high vector density, animal reservoirs ambient environmental and ecological factors, susceptible population and absence of regular insecticidal spraying in Nepal by the concerned institutions.
